Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota - PubMed (original) (raw)
Randomized Controlled Trial
Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota
Kyoto Imase et al. Microbiol Immunol. 2008 Mar.
Free article
Abstract
Antibiotic associated diarrhea due to human intestinal microbiota abnormalities is a side effect of H. pylori eradication therapy. We examined intestinal microbiota changes during H. pylori eradication therapy and the preventive effect of CBM588 as a probiotic agent. Nineteen patients with gastro-duodenal ulcer were randomly divided into three groups: group A (without probiotics), group B (with regular doses of CBM588) and group C (with double doses of CBM588). The incidence of diarrhea and soft stools during H. pylori eradication therapy was 43% in group A and 14% in group B, while none of the patients in group C reported diarrhea or soft stools. Both bacterial counts and detection rates of bifidobacteria and/or obligate anaerobe were decreased by eradication therapy. However, bacterial counts of obligate anaerobes in group C were significantly higher than in group A (P < 0.05). Additionally, during eradication therapy C. difficile toxin A was detected in both group A and group B but not in group C. In conclusion, these results indicate that H. pylori eradication therapy induces antibiotic associated diarrhea due to abnormalities in intestinal microbiota and/or C. difficile. However, these side effects might be prevented by probiotics.
Similar articles
- Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A. Cremonini F, et al. Am J Gastroenterol. 2002 Nov;97(11):2744-9. doi: 10.1111/j.1572-0241.2002.07063.x. Am J Gastroenterol. 2002. PMID: 12425542 Clinical Trial. - The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS. Kim MN, et al. Helicobacter. 2008 Aug;13(4):261-8. doi: 10.1111/j.1523-5378.2008.00601.x. Helicobacter. 2008. PMID: 18665934 Clinical Trial. - Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW, Lee SW, Hyun JJ, Kim DI, Koo JS, Yim HJ, Park JJ, Lee HS, Chun HJ, Um SH, Choi JH, Kim CD, Ryu HS. Jung SW, et al. Dig Liver Dis. 2009 Feb;41(2):134-40. doi: 10.1016/j.dld.2008.03.005. Epub 2008 Apr 23. Dig Liver Dis. 2009. PMID: 18436489 - Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori.
Wilhelm SM, Johnson JL, Kale-Pradhan PB. Wilhelm SM, et al. Ann Pharmacother. 2011 Jul;45(7-8):960-6. doi: 10.1345/aph.1Q104. Epub 2011 Jun 21. Ann Pharmacother. 2011. PMID: 21693698 Review. - Helicobacter pylori: microbiology and interactions with gastrointestinal microflora.
Dzierzanowska-Fangrat K, Dzierzanowska D. Dzierzanowska-Fangrat K, et al. J Physiol Pharmacol. 2006 Sep;57 Suppl 3:5-14. J Physiol Pharmacol. 2006. PMID: 17033102 Review.
Cited by
- The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-Radiotherapy.
Cazzaniga M, Cardinali M, Di Pierro F, Zonzini GB, Palazzi CM, Gregoretti A, Zerbinati N, Guasti L, Bertuccioli A. Cazzaniga M, et al. Int J Mol Sci. 2024 Feb 15;25(4):2306. doi: 10.3390/ijms25042306. Int J Mol Sci. 2024. PMID: 38396981 Free PMC article. - The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV.
Yang Q, Zaongo SD, Zhu L, Yan J, Yang J, Ouyang J. Yang Q, et al. Probiotics Antimicrob Proteins. 2024 Aug;16(4):1465-1482. doi: 10.1007/s12602-024-10227-1. Epub 2024 Feb 9. Probiotics Antimicrob Proteins. 2024. PMID: 38336953 Review. - Adequate amounts of probiotics increase the success rate of Helicobacter pylori eradication therapy in children.
Kakiuchi T. Kakiuchi T. Therap Adv Gastroenterol. 2023 Aug 24;16:17562848231191669. doi: 10.1177/17562848231191669. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37655060 Free PMC article. No abstract available. - Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases.
Bi M, Liu C, Wang Y, Liu SJ. Bi M, et al. Microorganisms. 2023 Jun 8;11(6):1527. doi: 10.3390/microorganisms11061527. Microorganisms. 2023. PMID: 37375029 Free PMC article. Review. - Fermented rice bran supplementation ameliorates obesity via gut microbiota and metabolism modification in female mice.
Tochitani S, Maehara Y, Kawase T, Tsukahara T, Shimizu R, Watanabe T, Maehara K, Asaoka K, Matsuzaki H. Tochitani S, et al. J Clin Biochem Nutr. 2022 Mar;70(2):160-174. doi: 10.3164/jcbn.21-96. Epub 2021 Nov 10. J Clin Biochem Nutr. 2022. PMID: 35400825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical